Active Stocks
Tue Apr 16 2024 15:59:30
  1. Tata Steel share price
  2. 160.05 -0.53%
  1. Infosys share price
  2. 1,414.75 -3.65%
  1. NTPC share price
  2. 359.40 -0.54%
  1. State Bank Of India share price
  2. 751.90 -0.65%
  1. HDFC Bank share price
  2. 1,509.40 0.97%
Business News/ Companies / News/  Ranbaxy case: Delhi HC seeks details of exchange-listed shares held by Singh brothers
BackBack

Ranbaxy case: Delhi HC seeks details of exchange-listed shares held by Singh brothers

Delhi HC asks court-appointed commissioner to submit a list of unpledged shares held by ex-Ranbaxy promoters in relation to the enforcement of Rs3,500 crore arbitration case with Daiichi Sankyo

Daiichi Sankyo’s plea seeking a stay on sale of assets of Fortis Healthcare Limited would be taken up at a later stage by the court. Photo: Hindustan TimesPremium
Daiichi Sankyo’s plea seeking a stay on sale of assets of Fortis Healthcare Limited would be taken up at a later stage by the court. Photo: Hindustan Times

New Delhi: The Delhi high court on Wednesday asked a court-appointed chartered accountant to submit a list of all exchange-listed unpledged shares held by former Ranbaxy promoters Malvinder Mohan Singh and Shivinder Mohan Singh and others in relation to the enforcement of a Rs3,500 crore arbitration case with Japanese drug maker Daiichi Sankyo Co. Ltd.

Subject to the permission of the court, the shares so listed would be sold by a court appointed Commissioner and the proceeds would be deposited with the court towards the satisfaction of the arbitration award in favour of Daiichi Sankyo.

The order was passed by a bench comprising Justice Jayant Nath pursuant to Daiichi Sankyo’s plea seeking the execution of the court’s 31January order upholding the enforceability of a Rs3,500 crore arbitration award against the Singh brothers and others.

Daiichi Sankyo’s plea seeking a stay on sale of assets of Fortis Healthcare Limited would be taken up at a later stage by the court.

On 31 January, the Delhi high court had upheld the enforceability of the award passed by a Singapore tribunal which had found the Singh brothers and others guilty of making false claims in a self-assessment report, and of misrepresenting and concealing the “genesis, nature and severity of the US regulatory investigations" into Ranbaxy when Daiichi bought their 34.82% stake for $2.4 billion in 2008.

The deal value was $4.6 billion.

On 23 March, the high court had attached all moveable property disclosed in an affidavit by Singh brothers and others.

On 26 February, all assets disclosed by Oscar Investments Ltd and RHC Holding Pvt. Ltd, owned by the Singh brothers, were also attached by an order of the high court.

The matter would be next heard on 8 May.

Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!

Catch all the Corporate news and Updates on Live Mint. Download The Mint News App to get Daily Market Updates & Live Business News.
More Less
Published: 25 Apr 2018, 10:23 PM IST
Next Story footLogo
Recommended For You
Switch to the Mint app for fast and personalized news - Get App